Calpain-induced Bax-cleavage product is a more potent inducer of apoptotic cell death than wild-type Bax

Cancer Letters

Volumn 189, Issue 2, 2003, Pages 221-230

  Toyota, Hiroko ^a   Yanase, Noriko ^a   Yoshimoto, Takayuki ^a   Moriyama, Masami ^b   Sudo, Tetsuo ^c   Mizuguchi, Junichiro ^a  

^a TOKYO MEDICAL UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c TORAY INDUSTRIES INC   (Japan)

Author keywords

Apoptosis; Bax; BcL xL; Calpain; Cleavage

Indexed keywords

AMINO ACID; CALPAIN; PROTEIN BAX; PROTEIN BCL X;

AMINO ACID SEQUENCE; APOPTOSIS; ARTICLE; CELL DEATH; COMPLEX FORMATION; CONTROLLED STUDY; DRUG TARGETING; HUMAN; HUMAN CELL; MOLECULE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN DEGRADATION; TUMOR;

ADENOCARCINOMA; AMINO ACID MOTIFS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; BCL-X PROTEIN; CALPAIN; CELL LINE; CODON; COLONIC NEOPLASMS; HUMANS; KIDNEY; MUTAGENESIS, SITE-DIRECTED; PEPTIDE FRAGMENTS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-BCL-2; SUBSTRATE SPECIFICITY; TUMOR CELLS, CULTURED;

EID: 0037469097     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(02)00552-9     Document Type: Article

References (38)

1. Raff M.C. Social controls on cell survival and cell death. Nature. 356:1992;397-400.
2. Reed J.C. Bcl-2 family proteins. Oncogene. 17:1998;3225-3236.
3. Goping I.S., Gross A., Lavoie J.N., Nguyen M., Jemmerson R., Roth K., Korsmeyer S.J., Shore G.C. Regulated targeting of BAX to mitochondria. J. Cell Biol. 143:1998;207-215.
4. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139:1997;1281-1292.
5. Oltvai Z.N., Milliman C.L., Korsmeyer S.J. Bcl-2 heterodimerizes in vivo with a conserved homolog Bax, that accelerates programmed cell death. Cell. 74:1993;609-619.
6. Schlesinger P.H., Gross A., Yin X.M., Yamamoto K., Saito M., Waksman G., Korsmeyer S.J. Comparison of the ion channel characteristics of proapoptotic BAX and antiapoptotic BCL-2. Proc. Natl. Acad. Sci. USA. 94:1997;11357-11362.
7. Shimizu S., Ide T., Yanagida T., Tsujimoto Y. Electrophysiological study of a novel large pore formed by Bax and the voltage-dependent anion channel that is permeable to cytochrome c. J. Biol. Chem. 275:2000;12321-12325.
8. Marzo I., Brenner C., Zamzami N., Jurgensmeier J.M., Susin S.A., Vieira H.L., Prevost M.C., Xie Z., Matsuyama S., Reed J.C., Kroemer G. Bax and adenine nucleotide translocator cooperate in the mitochondrial control of apoptosis. Science. 281:1998;2027-2031.
9. Yanase N., Takada E., Yoshihama I., Ikegami H., Mizuguchi J. Participation of Bax-alpha in IFN-alpha-mediated apoptosis in Daudi B lymphoma cells. J. Interferon Cytokine Res. 18:1998;855-861.
10. Wood D.E., Thomas A., Devi L.A., Berman Y., Beavis R.C., Reed J.C., Newcomb E.W. Bax cleavage is mediated by calpain during drug-induced apoptosis. Oncogene. 17:1998;1069-1078.
11. Wood D.E., Newcomb E.W. Caspase-dependent activation of calpain during drug-induced apoptosis. J. Biol. Chem. 274:1999;8309-8315.
12. Yanase N., Ohshima K., Ikegami H., Mizuguchi J. Cytochrome c release, mitochondrial membrane depolarization, caspase-3 activation, and Bax-alpha cleavage during IFN-alpha-induced apoptosis in Daudi B lymphoma cells. J. Interferon Cytokine Res. 20:2000;1121-1129.
13. Choi W.S., Lee E.H., Chung C.W., Jung Y.K., Jin B.K., Kim S.U., Oh T.H., Saido T.C., Oh Y.J. Cleavage of Bax is mediated by caspase-dependent or -independent calpain activation in dopaminergic neuronal cells: protective role of Bcl-2. J. Neurochem. 77:2001;1531-1541.
14. L) during carboplatin-mediated apoptosis in squamous cell carcinoma cell line. Oral Oncol. 36:2000;277-285.
15. Nishi T., Takahashi M., Ito H., Yoshihama I., Takada E., Mizuguchi J. Participation of Bcl-2/Bax-alpha in glutamate-induced apoptosis of human glioblastoma cells. J. Neurooncol. 44:1999;109-117.
16. Wang W., Creutz C.E. Role of the amino-terminal domain in regulating interactions of annexin I with membranes: effects of amino-terminal truncation and mutagenesis of the phosphorylation sites. Biochemistry. 33:1994;275-282.
17. Mizuguchi J., Yamanashi Y., Ehara K., Tamura T., Nariuchi H., Gyotoku Y., Fukazawa H., Uehara Y., Yamamoto T. Tyrosine protein kinase is involved in anti-1gM-mediated signaling in BAL17 B lymphoma cells. J. Immunol. 148:1992;689-694.
18. Rampino N., Yamamoto H., Ionov Y., Li Y., Sawai H., Reed J.C., Perucho M. Somatic frameshift mutations in the BAX gene in colon cancers of the microsatellite mutator phenotype. Science. 275:1997;967-969.
19. Nechushtan A., Smith C.L., Hsu Y.T., Youle R.J. Conformation of the Bax C-terminus regulates subcellular location and cell death. EMBO J. 18:1999;2330-2341.
20. L) confers multi-drug resistance in several squamous cell carcinoma cell lines. Oral Oncol. 38:2002;41-48.
21. L. J. Biol. Chem. 274:1999;2225-2233.
22. Chao D.T., Korsmeyer S.J. BCL-2 family: regulators of cell death. Annu. Rev. Immunol. 16:1998;395-419.
23. Gross A., McDonnell J.M., Korsmeyer S.J. BCL-2 family members and the mitochondria in apoptosis. Genes Dev. 13:1999;1899-1911.
24. Kroemer G. The proto-oncogene Bcl-2 and its role in regulating apoptosis. Nat. Med. 3:1997;614-620.
25. Carafoli E., Molinari M. Calpain: a protease in search of a function? Biochem. Biophys. Res. Commun. 247:1998;193-203.
26. Thomas A., El Rouby S., Reed J.C., Krajewski S., Silber R., Potmesil M., Newcomb E.W. Drug-induced apoptosis in B-cell chronic lymphocytic leukemia: relationship between p53 gene mutation and bcl-2/bax proteins in drug resistance. Oncogene. 12:1996;1055-1062.
27. Chen Q., Gong B., Almasan A. Distinct stages of cytochrome c release from mitochondria: evidence for a feedback amplification loop linking caspase activation to mitochondrial dysfunction in genotoxic stress induced apoptosis. Cell Death Differ. 7:2000;227-233.
28. Gao G., Dou Q.P. N-terminal cleavage of bax by calpain generates a potent proapoptotic 18-kDa fragment that promotes bcl-2-independent cytochrome C release and apoptotic cell death, J. Cell Biochem. 80:2000;53-72.
29. Kawasaki H., Kawashima S. Regulation of the calpain-calpastatin system by membranes (review). Mol. Membr. Biol. 13:1996;217-224.
30. Thornberry N.A., Rano T.A., Peterson E.P., Rasper D.M., Timkey T., Garcia-Calvo M., Houtzager V.M., Nordstrom P.A., Roy S., Vaillancourt J.P., Chapman K.T., Nicholson D.W. A combinatorial approach defines specificities of members of the caspase family and granzyme B; functional relationships established for key mediators of apoptosis. J. Biol. Chem. 272:1997;17907-17911.
31. Pawlowski J., Kraft A.S. Bax-induced apoptotic cell death. Proc. Natl. Acad. Sci. USA. 97:2000;529-531.
32. Wood D.E., Newcomb E.W. Cleavage of Bax enhances its cell death function. Exp. Cell Res. 256:2000;375-382.
33. Hsu Y.T., Youle R.J. Bax in murine thymus is a soluble monomeric protein that displays differential detergent-induced conformations. J. Biol. Chem. 273:1998;10777-10783.
34. Simonen M., Keller H., Heim J. The BH3 domain of Bax is sufficient for interaction of Bax with itself and with other family members and it is required for induction of apoptosis. Eur. J. Biochem. 249:1997;85-91.
35. L, an inhibitor of programmed cell death. Nature. 381:1996;335-341.
36. Eskes R., Desagher S., Antonsson B., Martinou J.C. Bid induces the oligomerization and insertion of Bax into the outer mitochondrial membrane. Mol. Cell Biol. 20:2000;929-935.
37. L can confer a multidrug resistance phenotype. Blood. 86:1995;1903-1910.
38. Tai Y.T., Strobel T., Kufe D., Cannistra S.A. In vivo cytotoxicity of ovarian cancer cells through tumor-selective expression of the BAX gene. Cancer Res. 59:1999;2121-2126.